RKDA - Arcadia Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
5.53
+0.19 (+3.56%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close5.34
Open5.37
Bid0.00 x 2900
Ask0.00 x 2900
Day's Range5.37 - 5.63
52 Week Range1.82 - 10.40
Volume186,449
Avg. Volume570,217
Market Cap48M
Beta (5Y Monthly)-3.01
PE Ratio (TTM)N/A
EPS (TTM)-4.30
Earnings DateNov 6, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.00
  • Arcadia introduces GoodHemp at national seed expo in Chicago
    American City Business Journals

    Arcadia introduces GoodHemp at national seed expo in Chicago

    Davis-based Arcadia Biosciences Inc. launched its new GoodHemp product Tuesday at the American Seed Trade Association CSS & Seed Expo in Chicago.

  • Benzinga

    Arcadia Bio Launches Hemp Seeds Brand: 'Just The Beginning Of Our Ambitions'

    The new brand will focus on developing “genetically superior” hemp seeds, transplants, flower and extracts. The first commercial product is a disease-resistant, ultra-low THC hemp seed. “With GoodHemp, we have a disruptive new commercial hemp seed portfolio as well as a rich pipeline of powerful new genetics that solve a major industry problem - hot crops that test above the USDA’s stringent .3 percent THC limit," Sarah Reiter, COO of Arcadia Biosciences, told Benzinga.

  • Arcadia Biosciences Launches GoodHemp, a New Commercial Brand of Superior Hemp Seeds, with an Ultra-Low THC Variety Available for Order this Month
    PR Newswire

    Arcadia Biosciences Launches GoodHemp, a New Commercial Brand of Superior Hemp Seeds, with an Ultra-Low THC Variety Available for Order this Month

    Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the launch of a new product line: GoodHemp. As the company's new commercial brand for delivering genetically superior hemp seeds, transplants, flower and extracts, GoodHemp will debut its first commercial product, a disease resistant and ultra-low THC hemp seed, during the American Seed Trade Association CSS & Seed Expo on December 11.

  • Thomson Reuters StreetEvents

    Edited Transcript of RKDA earnings conference call or presentation 6-Nov-19 9:30pm GMT

    Q3 2019 Arcadia Biosciences Inc Earnings Call

  • VEXT Reports 36% Revenue Increase, 7% Increase in Net Income for Year to Date 2019
    CNW Group

    VEXT Reports 36% Revenue Increase, 7% Increase in Net Income for Year to Date 2019

    VEXT Reports 36% Revenue Increase, 7% Increase in Net Income for Year to Date 2019

  • PR Newswire

    Verdeca Receives Approval of HB4® Drought and Herbicide Tolerant Soybeans in Paraguay

    The HB4 stack is Verdeca's newest product release from its pipeline of traits developed to benefit soybean producers through quality improvement, stress mitigation and management practices. "HB4 is a novel soybean trait that enhances the traditional herbicide tolerance package to provide yield stability across diverse environments," said Martin Mariani Ventura, general manager of Verdeca.

  • Business Wire

    Approval of HB4® Drought and Herbicide Tolerant Soybeans in Paraguay

    -- Novel trait stack expected to help growers facing climate and production challenges -- 

  • Benzinga

    Arcadia Biosciences Falls On Quarterly Net Loss of $14.2M, CEO Says Hemp Research 'More Valuable Than Ever'

    The company posted a net loss for the quarter of $14.2 million, or $2.04 per share, representing a 419% decrease from the $4.5-million in net income in the corresponding period in 2018. For the first nine months of 2019, Arcadia reported a net loss of $22.6 million versus a net loss of $12.8 million for the same period in 2018. Larger net losses in both periods was mostly because of the adjustment in the fair value of the common stock warrant and common stock adjustment feature liabilities, the company said in a press release.

  • Arcadia Biosciences Announces Third-Quarter 2019 Financial Results and Business Highlights
    PR Newswire

    Arcadia Biosciences Announces Third-Quarter 2019 Financial Results and Business Highlights

    -- Company announces plans for hemp seed sales, highlights first GoodWheat™ sales commitments and USDA approval of HB4® soybeans -- DAVIS, Calif. , Nov. 6, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. ...

  • Arcadia shares rise on GoodWheat contract announcement
    American City Business Journals

    Arcadia shares rise on GoodWheat contract announcement

    Shares in Davis-based Arcadia Biosciences Inc. rose nearly 19% on Tuesday after the seed research company said it has committed buyers for its high-fiber GoodWheat product.

  • Arcadia Biosciences Announces Wheat Purchase Commitment, Significant Increase in GoodWheat™ Harvest Acres
    PR Newswire

    Arcadia Biosciences Announces Wheat Purchase Commitment, Significant Increase in GoodWheat™ Harvest Acres

    DAVIS, Calif., Nov. 5, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced it has secured its first purchase commitment for its high-fiber bread wheat for 2020 through its North American partner Bay State Milling Company. Earlier this year, Arcadia announced Bay State Milling would be the exclusive North American commercial partner for its high-fiber bread wheat under Bay State Milling's HealthSense™ brand portfolio. "Arcadia's high-fiber wheat technology expands our HealthSense portfolio and strengthens our robust supply chain of identity preserved non-GM wheat varieties," said Peter Levangie, president and CEO of Bay State Milling.

  • Arcadia Biosciences Announces Date of Third-Quarter 2019 Financial Results and Business Highlights Conference Call
    PR Newswire

    Arcadia Biosciences Announces Date of Third-Quarter 2019 Financial Results and Business Highlights Conference Call

    DAVIS, Calif. , Oct. 30, 2019 /PRNewswire/ --  Arcadia Biosciences, Inc.  (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops, today announced that ...

  • Yolo County continues outdoor ban on high-value crop, to protect cannabis
    American City Business Journals

    Yolo County continues outdoor ban on high-value crop, to protect cannabis

    For at least a while longer, it will be illegal for farmers to grow commercial hemp in the open in Yolo County, even as psychoactive cannabis is legal.

  • Did You Manage To Avoid Arcadia Biosciences's (NASDAQ:RKDA) Devastating 85% Share Price Drop?
    Simply Wall St.

    Did You Manage To Avoid Arcadia Biosciences's (NASDAQ:RKDA) Devastating 85% Share Price Drop?

    Arcadia Biosciences, Inc. (NASDAQ:RKDA) shareholders will doubtless be very grateful to see the share price up 71% in...

  • Benzinga

    Arcadia Biosciences Updates Joint Venture With Archipelago Ventures

    Arcadia Biosciences, Inc. (NASDAQ: RKDA) released Tuesday an update on its joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures. It has also brought in a new autoflowering hemp varietal to Hawaii’s pilot program to attain year-round growth cycles. Furthermore, the joint venture has developed mobile extraction and processing equipment to produce THC-free, sun-grown hemp isolate or distillate.

  • Arcadia Biosciences Advances Hemp Operations with Archipelago Ventures
    PR Newswire

    Arcadia Biosciences Advances Hemp Operations with Archipelago Ventures

    DAVIS, Calif., Oct. 15, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today issued an update on its recently formed joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures. Expanded its cultivation footprint on Hawaii by 3x, from 10 to 30 acres, through partnerships with two new license holders. Archipelago is seeding the new acreage this month and expects to employ both permanent and seasonal staffers locally to execute the research plan involving crop management and harvest of several new varieties.

  • Arcadia Biosciences Granted U.S. Patent for Reduced Gluten GoodWheat
    PR Newswire

    Arcadia Biosciences Granted U.S. Patent for Reduced Gluten GoodWheat

    DAVIS, Calif., Sept. 23, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the U.S. Patent and Trademark Office has awarded the company a patent for reduced gluten grains. This unique attribute was developed through Arcadia's in-house breeding platform, which brings novel food innovations to consumers. "This patent reaffirms Arcadia's position as a leader in crop innovation, particularly in optimizing crops for higher nutritional value," said Randy Shultz, Ph.D., vice president of research and development at Arcadia Biosciences.

  • Benzinga

    Cannabis Deals And M&A Picking Up Steam Again

    The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 800 M&A transactions.

  • Zacks Small Cap Research

    RKDA: Initiating Coverage of RKDA: Leveraging Gene-Editing Expertise to Target High Growth Markets

    By Brian Marckx, CFA NASDAQ:RKDA | OTC:VAPNF READ THE FULL RKDA RESEARCH REPORT SNAPSHOT: Anticipating Three Key Launches, Steepening Growth Curve Arcadia Biosciences, Inc (NASDAQ:RKDA) is an innovative agricultural company with a broad and growing product portfolio focused largely on improving the nutritional and other valued-added qualities of crops

  • Arcadia Biosciences Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market
    PR Newswire

    Arcadia Biosciences Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market

    DAVIS, Calif., Sept. 10, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced the closing of its previously announced registered direct offering of 1,318,828 shares of its common stock. The offering was priced at-the-market at a purchase price per share of $7.52, for gross proceeds of approximately $9.92 million. Additionally, in a concurrent private placement, Arcadia issued unregistered warrants to purchase up to 659,414 shares of common stock, representing 50 percent of the shares of common stock purchased in the registered direct offering.

  • Benzinga

    The Week In Cannabis: The Vape Craze, Raises Hit $10B, Aurora Cashes In On TGOD, Seth Rogen's Charity Goes Green

    On Thursday, the New York State Department of Health came out with a theory around vitamin E acetate being the culprit. Meanwhile, Washington, D.C. enacted a law that provides protections to government employees who consume medical marijuana. While many were investing in the cannabis space, Aurora Cannabis Inc. (NYSE: ACB) has started cashing out on some of its investments.

  • Benzinga

    A Subsidiary Of Arcadia Bio Received A New Hemp License In California

    Arcadia Specialty Genomics, a hemp-focused operating unit of crop innovation company Arcadia Biosciences Inc (NASDAQ: RKDA ), announced this week plans for a new sun-grown hemp cultivation and agronomic ...

  • Arcadia Biosciences Announces $10 Million Registered Direct Offering Priced At-the-Market
    PR Newswire

    Arcadia Biosciences Announces $10 Million Registered Direct Offering Priced At-the-Market

    DAVIS, Calif., Sept. 6, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase of 1,318,828 shares of its common stock, at a purchase price per share of $7.5825, in a registered direct offering priced at-the-market. Additionally, Arcadia has agreed to issue to the investors unregistered warrants to purchase up to 659,414 shares of common stock. The warrants to purchase up to 659,414 shares of common stock have an exercise price of $7.52 per share, will be immediately exercisable, and will expire five and one-half years from the issue date.

  • Arcadia Biosciences to Present at 21st Annual Global Investment Conference September 8-10, 2019
    PR Newswire

    Arcadia Biosciences to Present at 21st Annual Global Investment Conference September 8-10, 2019

    DAVIS, Calif. , Sept. 4, 2019 /PRNewswire/ --  Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, ...